Vitamin D2 (ergocalciferol) and D3 (cholecalciferol) can be procured from exogenous sources. These are then metabolized to 25-hydroxyvitamin D (25OHD2 and 25OHD3) in the liver. Measuring the levels of both 25OHD2 and 25OHD3 is imperative in assessing clinical nutritional status [1] . Vitamin D2 or D3 is provided as a vitamin D supplement in many countries.
Serum 25OHD levels can be measured by competitive binding assay, RIA, automated immunoassay, HPLC, and by the recently developed liquid chromatography-tandem mass spectrometry (LC-MS/MS) technique. LC-MS/MS is considered as the "gold standard" for the detection and quantification of 25OHD2 and 25OHD3. The MS/MS Vitamin D kit from PerkinElmer (PerkinElmer, Waltham, MA, USA) is a commercial reagent kit, intended for the quantitative determination of 25OHD2 and 25OHD3. The MS/MS Vitamin D kit protocol was compared with the following assays: RIA from DiaSorin (DiaSorin, Stillwater, MN, USA) and automated electro-chemiluminescence immunoassay (ECLIA) from Roche (Roche Diagnostics GmbH, Mannheim, Germany).
After receiving approval by the Ethics Review Board of the Cheil General Hospital and Women's Healthcare Centre (Seoul, Korea), consecutive samples (n = 50) sent for routine 25OHD analysis were used. The MS/MS Vitamin D kit was used along with the MS/MS Vitamin D Derivatization Box (PerkinElmer) on an LC-MS/MS system that included ACQUITY TQD tandem mass spectrometer (Waters, Milford, MA, USA). The MS/MS Vitamin D kit was compared with 25OHD 125I-based RIA kit and Elecsys Vitamin D Total assay. The MS/MS Vitamin D kit, RIA kit, and Elecsys Vitamin D Total assay were run according to the manufacturers' specifications. All three assays were compared by linear regression and Bland-Altman plot. The correlation between the methods was compared by using Pearson's correlation coefficient. Agreement in the assessment of the vitamin D status between methods was evaluated by using Cohen's kappa [2] . Precision of the LC-MS/MS method was evaluated by inter-assay CV (n = 20) of quality control materials supplied by the manufacturer. At the three levels of 25OHD2, CV was < 4.0%. At the three levels of 25OHD3, CV was < 5.3%. Inter-assay CV for RIA and ECLIA were < 13.0% and < 9.8%, respectively.
A (Fig. 1A) , with an average bias of +8.4 ng/ mL (15.4%) (Fig. 1C) , and the RIA demonstrated an R 2 value of 0.8976 (Fig. 1B) , with an average bias of +0.6 ng/mL (1.9%) (Fig. 1D) . This trend was also demonstrated in previous reports, with ECLIA showing positive bias compared with LC-MS/MS [2, 3] . The distribution of results for 25OHD2 and 25OHD3 is shown in Fig. 2 . The 25OHD3 levels showed no significant difference ( Fig. 2A) , while the 25OHD2 levels were biased towards the lower end (Fig. 2B) . 
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